Not applicableStudy completedNCT01262534What this trial is testingAssess the Clinical Profile of Patients in Spain With Moderate to Severe Psoriasis.Who this might be right forPsoriasis Janssen-Cilag, S.A. 1,042
Testing effectiveness (Phase 2)Active Not RecruitingNCT06591273What this trial is testingEfficacy and Safety of Infliximab Biosimilar in Treatment of Moderate to Severe Psoriasis; A Single-arm Clinical TrialWho this might be right forModerate to Severe Chronic Plaque Psoriasis Services Institute of Medical Sciences, Pakistan 104
Testing effectiveness (Phase 2)Study completedNCT02622386What this trial is testingThe Effect of Riboflavin on Moderate to Severe Plaque Type PsoriasisWho this might be right forPsoriasis University of Michigan 23
Large-scale testing (Phase 3)Looking for participantsNCT07130604What this trial is testingEvaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis InventisBio Co., Ltd 390
Large-scale testing (Phase 3)Study completedNCT01640951What this trial is testing4 Year Extension Study of Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Chronic Plaque-type PsoriasisWho this might be right forModerate to Severe Chronic Plaque-Type Psoriasis Novartis Pharmaceuticals 675
Post-approval studies (Phase 4)Study completedNCT00669214What this trial is testingEvaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the ScalpWho this might be right forPsoriasis Genentech, Inc. 89
Large-scale testing (Phase 3)Study completedNCT00691964What this trial is testingStudy Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPlaque Psoriasis AbbVie (prior sponsor, Abbott) 347
Large-scale testing (Phase 3)Study completedNCT03849404What this trial is testingEfficacy, Safety, and Immunogenicity of AVT02 With Moderate-to-Severe Chronic Plaque PsoriasisWho this might be right forPlaque Psoriasis Alvotech Swiss AG 413
Testing effectiveness (Phase 2)Study completedNCT06542614What this trial is testingTreatment of Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 209
Not applicableWithdrawnNCT04423471What this trial is testingNeuroinflammation, Affective and Cognitive Symptoms in Major Depression and PsoriasisWho this might be right forPsoriasisNeuroinflammationMajor Depressive Disorder+2 more Germans Trias i Pujol Hospital
Post-approval studies (Phase 4)Study completedNCT01265823What this trial is testingImmediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis AbbVie (prior sponsor, Abbott) 150
Large-scale testing (Phase 3)Study completedNCT03897088What this trial is testingEfficacy and Safety of Tildrakizumab in the Treatment of Scalp PsoriasisWho this might be right forScalp Psoriasis Sun Pharmaceutical Industries Limited 231
Not applicableEnded earlyNCT02775656What this trial is testingUCB Cimzia Pregnancy Follow-up StudyWho this might be right forRheumatoid Arthritis (RA)Crohn's Disease (CD)Psoriatic Arthritis (PsA)+1 more UCB BIOSCIENCES, Inc. 1
Large-scale testing (Phase 3)Not Yet RecruitingNCT06833307What this trial is testingThe Efficacy and Safety of SHR-1314 in the Treatment of Pediatric Patients of Age 6 to <18 Years With Moderate to Severe Plaque PsoriasisWho this might be right forChildren and Adolescents Aged 6 to 18 With Moderate-to-Severe Plaque Psoriasis Suzhou Suncadia Biopharmaceuticals Co., Ltd. 90
Large-scale testing (Phase 3)Study completedNCT03316781What this trial is testingStudy of Efficacy and Safety of HLX03 in Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Shanghai Henlius Biotech 262
Large-scale testing (Phase 3)Study completedNCT01232283What this trial is testingStudy to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.Who this might be right forPlaque Psoriasis Amgen 413
Testing effectiveness (Phase 2)Study completedNCT01899729What this trial is testingA 12-week Dose-Ranging Trial in Patients With Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Idera Pharmaceuticals, Inc. 46
Very early researchUnknownNCT04414605What this trial is testingOral Chinese Herbal Medicine Concurrent With Secukinumab for Severe Plaque PsoriasisWho this might be right forPsoriasis Guangdong Provincial Hospital of Traditional Chinese Medicine 10
Early research (Phase 1)Study completedNCT05342428What this trial is testingSafety and Efficacy of TLL018 in Patients With Plaque PsoriasisWho this might be right forModerate to Severe Plaque Psoriasis Hangzhou Highlightll Pharmaceutical Co., Ltd 73
Large-scale testing (Phase 3)Study completedNCT02850965What this trial is testingEfficacy, Safety and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis Boehringer Ingelheim 318